Clinical Trial Update: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety, efficacy, and pharmacokinetics of Rituximab in diffuse large B-cell lymphoma and follicular lymphoma has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2020-08-13